Healthcare

Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025

Management will participate in two upcoming investor healthcare conferencesSALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…

8 months ago

Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025

Management will participate in two upcoming investor healthcare conferencesSALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…

8 months ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare…

8 months ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare…

8 months ago

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

8 months ago

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…

8 months ago

iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)

iCAD collaborates with Microsoft to offer radiology providers the option for automated patient reporting on mammography results through PowerScribe integrationNASHUA,…

8 months ago

Fangzhou at the Forefront of AI-Healthcare Push as China Issues Pharmaceutical Industry Digital Transformation Roadmap

GUANGZHOU, China, April 29, 2025 /PRNewswire/ -- Recently, seven Chinese regulatory bodies including the Ministry of Industry and Information Technology…

8 months ago

Cosmo Receives Negative CHMP Opinion on Winlevi(R) (clascoterone Cream 1%) in Europe and Will Appeal the Decision

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX:…

8 months ago

Cosmo Publishes Agenda of AGM 2025

Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo” or the “Company”) today…

8 months ago